This inventor holds 2 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Novartis Ag, Suzhou Novartis Technical Development Co., Ltd.. Active years: 2016-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2026
Title: Ross Sinclair Strang: Innovator in Pharmaceutical Chemistry
Introduction
Ross Sinclair Strang is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific enzyme activities.
Latest Patents
One of his key patents is related to tetrahydro-pyrido-pyrimidine derivatives. This invention pertains to substituted tetrahydro-pyrido-pyrimidine derivatives of the formula (I), wherein Y, R, and m are defined in the description. These compounds are particularly suitable for the treatment of disorders or diseases mediated by the activity of the PI3K enzymes. Ross holds 1 patent in this area.
Career Highlights
Ross Sinclair Strang is associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative solutions in drug development and therapeutic applications.
Collaborations
Throughout his career, Ross has collaborated with esteemed colleagues, including Nigel Graham Cooke and Frédèric Zecri. These collaborations have further enhanced the impact of his research and inventions.
Conclusion
Ross Sinclair Strang is a prominent figure in the field of pharmaceutical innovation, with a focus on developing compounds that address critical health issues. His contributions continue to influence the landscape of drug development and therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile